Erythematous maculopapular eruption due to rivastigmine therapy.
Monastero
R
R
Lopez
G
G
Mannino
M
M
Camarda
R
R
D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy; D002219:Carbamates / Q000009:adverse effects* / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D010267:Parapsoriasis / Q000139:chemically induced*; D048448:Phenylcarbamates; D000068836:Rivastigmine
D002219:Carbamates; D002800:Cholinesterase Inhibitors; D048448:Phenylcarbamates; D000068836:Rivastigmine